r***i
发帖数: 31 | 1 2012 CABA Investment, Innovation & Entrepreneurship Symposium
2012美中生物医药协会投资,创新与创业研讨会
Time: Oct 20, 2012 1PM to 9PM; Location: The double tree suite, Boston, MA
http://www.cpnweb.org/
The theme of 2012 CABA Investment, Innovation & Entrepreneurship Symposium
will be on “Opportunities for Biopharmaceutical Investors and Entrepreneurs
”. This year’s symposium will provide a unique forum where industry
executives, entrepreneurs, scientists, academics, government policy makers,
and professionals from financial and investment communities engage in an in-
depth discussion on business, investment and start-up opportunities at a
time of increased pharma consolidation and externalization.
The highlights for this year’s discussion
Drug R&D and US-China biomedical exchange
Government’s impacts on biotech/pharmaceutical industries
Consolidation and Externalization
Successful biotech entrepreneur stories
Business and startup opportunities
Conference Organizing Committee
Chair: XIANGYANG YU
Co-Chairs: QINGQING CAO, STEVE DU, HAO LI
Committee
QINGLIN CHE ZHIHONG CHEN CHAOYANG DAI ELLEN FAN SHIWEN LIN, TING REN ZHAO-
KUI (ZK) WAN YIHAN WANG LI XING PHILIP ZHANG
Admission
CABA, CAIPLA, OCEAN, ACMA, NECINA, 128CUTE members: FREE; Non-members: $20.
On-site membership registration to CABA available ($20 annual membership fee
due)
Driving Direction & Parking
Please enter the hotel parking garage from Storrow Drive. Parking is free.
Conference Agenda:
1:00PM –1:30PM Registration
1:30PM –1:32PM Opening
Xiangyang Yu, Ph.D., Conference Chair
1:32PM –1:35PM Welcome Address
Philip Zhang, Ph.D., J.D., President, CABA
1:35PM –2:10PM
Keynote Speech- Novartis Oncology Licensing Strategy & Process?
Anne Altmeyer, VP, Business Development – Novartis Oncology
2:10 PM -2:35PM
Accelerating Innovation in a Collaborative Biopharma Ecosystem
Hui Cai, Ph.D., MBA, WuXi AppTec Inc. VP, Corporate Alliances
2:35PM –3:00PM
Building the Pipeline Through In-Licensing: a Patient-centric Approach
Anthony P. Colasin, Head of In-Licensing and External R&D – Ironwood
Pharmaceuticals, Inc.
3:00PM –3:10PM Coffee Break
3:10 PM – 4:00PM Panel Discussion:
BioPharma’s Innovation & Entrepreneurship
Moderator: Hao Li, Ph.D., MBA, Novartis
Panelists:
Chaoyang Dai, VP, Acebright
Jinbo Lee, Ph.D. Chief Scientific Officer, Scilligence: Software for life
Sciences
Karl Qin, President and founder of Biopharma Vision LLC.
Ming Tong, MD, MBE, Senior Medical consultant & Director, Beijing Biopharma
International
4:00PM – 4:45PM
China Investment Opportunities
Introduction by Shiwen Lin, Ph.D., Associate Director, Agenus Inc
Ye Dongbo, Counselor of Science and Technology, Chinese Consulate in New
York
BioLake Investment Opportunities
4:45PM – 5:35 PM
Panel Discussion: 2012 Global Outsourcing Strategies & Trends
Moderator: Zhao-Kui(ZK) Wan, Ph.D. Pfizer
Panelists:
Charles Huang, VP of Global BD, Sundia MediTech Company
Hui Li, Ph.D., Head of BD, BioDuo/PPD
Declan Ryan, Ph.D., MBA, Executive Dir. BD, ChemPartner Shanghai
Lixin Shen, Ph.D., CEO, Wuxi Howfond Biopharma Co. , Ltd.
George Shi, PhD., CSO, Anichem, Inc.
Bing Yu, Ph.D., General Manager, GL Syntech
5:35PM Close of Afternoon Program
5:35PM – 6:30PM
Cocktail Reception/Social Networking
6:30PM – 6:35PM Welcome Address
Yihan Wang, Ph.D. Associate Dir. Ariad Pharmaceuticals, Inc.
6:45PM – 7:45PM Dinner
7:45PM – 8:30PM Event Keynote Speech: "Outlook for Chinese Science &
Technology Development"
Weizhong Wang, Ph.D., Vice Minister, Minister of Science & Technology of
China
8:30PM – 9:00PM Networking |
